| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |